Karmanos Cancer Insitute is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Karmanos Cancer Insitute has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Monoclonal Gammopathy, Smoldering Multiple Myeloma, Non-Small Cell Lung Cancer.
Sponsors: Dana-Farber Cancer Institute, Summit Therapeutics, Adaptimmune.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Karmanos Cancer Insitute has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Karmanos Cancer Insitute has 3 clinical trials on record, with 2 currently active. Their work covers Monoclonal Gammopathy, Smoldering Multiple Myeloma, Non-Small Cell Lung Cancer.
Karmanos Cancer Insitute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.